News | Prostate Cancer

ImaginAb Inc. has released interim results from a Phase 2 clinical trial of IAB2M, the company's proprietary imaging agent for management of prostate cancer. IAB2M demonstrated superior performance in detecting disease compared with ProstaScint and conventional imaging technologies including computed tomography (CT) scans, magnetic resonance imaging (MRI) scans and bone scans. In addition, the agent accurately detected metastatic disease in normal-sized lymph nodes, overcoming a major limitation of existing technologies and addressing a key clinical need.

Time September 14, 2015
Home
News | Mammography

The widespread practice of incentivizing mammogram completion via cash payments, typically by insurance companies, is unethical according to a Viewpoint article published recently in JAMA by an expert from the Perelman School of Medicine at the University of Pennsylvania. Instead, incentives should be offered to women to use evidence-based decision aids to decide if they want a mammogram, even if this policy likely averts fewer breast cancer deaths overall.

Time September 14, 2015
Home
News | Ultrasound Imaging

September 14, 2015 — University of Arkansas for Medical Sciences (UAMS) researcher Vladimir Zharov, Ph.D., D.Sc., was ...

Time September 14, 2015
Home
Feature | Radiation Therapy | Melinda Taschetta-Millane

The use of radiation therapy to treat cancer has been in existence for over a century, tracing back to the early days of ...

Time September 09, 2015
Home
Feature | Ultrasound Imaging | Jon Brubaker, MBA, RCVT and Katie Regan, MA

Navigating coverage decisions can be overwhelming and confusing, especially for high-end imaging equipment, where ...

Time September 10, 2015
Home
Feature | Information Technology

The buzz term “big data” has made a rapid entry onto the healthcare scene in the past couple years with promises of ...

Time September 09, 2015
Home
News | Magnetic Resonance Imaging (MRI)

Value-driven health platform Spreemo has completed the first phase of a study to determine how interpretative variability in magnetic resonance imaging (MRI), a standard diagnostic test, can influence the course of a patient’s treatment.

Time September 11, 2015
Home
News | Radiopharmaceuticals and Tracers

Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiopharmaceuticals, announced the arrival of a 70 MeV Cyclotron at its new production facility in Noblesville, Indiana.

Time September 11, 2015
Home
News | Radiopharmaceuticals and Tracers

Westinghouse Electric Company and NorthStar Medical Radioisotopes announced a memorandum of understanding to explore producing medical radioisotopes from the core of commercial nuclear reactors, and methods of global distribution. The exploration involves generating the most widely used radioisotope in medical diagnostic imaging by treating an isotope of the chemical element molybdenum rather than enriched uranium.

Time September 11, 2015
Home
News | Ultrasound Women's Health

Delphinus Medical Technologies Inc. announced that it has secured a venture round of $39.5 million, the single largest amount ever raised for a healthcare imaging company in the Midwest. It is also the largest amount for a medical device company in Michigan.

Time September 11, 2015
Home
News | Contrast Media

Tiny gas microbubbles can enhance the delivery and absorption of cancer drugs in patients with advanced pancreatic cancer, according to a new pilot study. The study was described at the International Contrast Ultrasound Society (ICUS) annual conference in Chicago.

Time September 11, 2015
Home
Feature | Radiation Therapy

Women who have breast cancer on their left side present a particular challenge to radiation oncologists. Studies have ...

Time September 10, 2015
Home
Feature | X-Ray | Greg Freiherr

The transition from film to flat panel has dramatically improved the efficiency of portable X-ray units. Transmitting ...

Time September 10, 2015
Home
Technology | Computed Tomography (CT)

September 9, 2015 — The U.S. Food and Drug Administration (FDA) granted 510(k) for Philips Healthcare’s Spectral ...

Time September 09, 2015
Home
Comparison Charts
Time
Home
News | Remanufactured Refurbished Equipment

Ninety-six percent of clinics and hospitals in the United States that have purchased used or refurbished medical equipment have had neutral-to-positive experiences with the purchase, according to a new survey.

Time September 09, 2015
Home
News | Mammography

More than 50 women in need received free cervical and breast cancer screenings with same-day results as part of a recent See, Test & Treat program and health fair at Loyola University Medical Center.

Time September 09, 2015
Home
News | Clinical Decision Support

SRI International and DataSpeaks Inc. announced that SRI has licensed the Science of Individuality Measurement Algorithm (SIMA) software from DataSpeaks. SRI will integrate SIMA into the development of a secure enterprise system for clinical decision-making.

Time September 09, 2015
Home
News | Radiation Therapy

Varian Medical Systems is collaborating with two leading Cape Town universities to launch Africa's first 'Access to Care' program, designed to train cancer caregivers in delivering advanced conformal radiotherapy treatments.

Time September 09, 2015
Home
Feature | Computed Tomography (CT) | Dave Fornell

When 64-slice computed tomography (CT) systems were introduced nearly a decade ago, they were purchased in large numbers ...

Time September 09, 2015
Home
Subscribe Now